SEMPORA ADVISES ADIUVA CAPITAL ON ACQUISITION OF ASCOPHARM GROUP
SEMPORA Consulting has conducted market and commercial due diligence in support of Adiuva Capital’s recent acquisition of the leading German mail order pharmacy business Ascopharm.
Adiuva Capital has acquired 100% of the share capital of Ascopharm Group from its founder Karl-Heinz Oppermann.
Thomas Golly, Managing Partner at SEMPORA Consulting, who led the commercial due diligence process on behalf of Adiuva, comments:
'Evaluating the effectiveness of Ascopharm’s specialised business model and its prospects required a deep understanding of mail order business, coupled with knowledge of the retail pharmacy environment, as well analysis of current customer profiles and their buying behaviour. As part of the commercial review Sempora carried out a detailed analysis of customer shopping behaviour, providing comprehensive customer insights and enabling assessment of marketing efficiency. These resulting insights also enabled us to systematically identify possible risks and future opportunities in support of Ascopharm’s business plan.'
Link to Adiuva Capital Press Release
Download Press Release